GUIDELINES AND CRITERIA

  • A panel of industry experts will evaluate and rate each nomination based on the write-up and supporting documents submitted.

To be eligible for an award, the project/service/initiative must be either:

  • Launched over the last 24 calendar months
  • Launched prior to 24 calendar months but had recent innovations to improve the project/service/initiative

Jury Special

The nominations were received for the following categories. One winner has been selected in each of these categories by an international jury panel**.

  • Emerging startup of the year 2024
  • Entrepreneur of the year
  • Technology/ product of the year
  • Person of the year

Emerging startup of the year 2024

  • Year of Inception
  • Location
  • Domain- Biopharma/Pharma/Diagnositc/Medtech/Bioservices
  • Founders' details
  • Total team strength
  • Total funds raised since inception
  • Investors' details
  • Revenue generated since inception
  • Key highlights of CY 2023
  • Challenges faced in CY 2023

Entrepreneur of the year 2024

  • Strategic steps that make the company stand out in the crowd in the past two years
  • Imaginative business plan which should have innovative products and services
  • Business results achieved
  • Ability to raise funds
  • Ability to attract top human talent

Technology/ product of the year 2024

  • Revenue realizations from the product in CY 2023
  • Uniqueness
  • Degree of difficulty in creating the product
  • Import substitution
  • Export potential
  • Price competitiveness

Person of the year 2024

  • Organisation Performance in CY 2023
  • Role Beyond Company-
  • Key Projects in CY 2023
  • Global Initiatives
  • Influence on policy making/ Fostering Industry Harmony
  • Stature as a leader in Asia

Industry Segment Special

The nominations were received for the following categories under the Industry Segment Special Awards 2024-

  • Top company for bioprocessing
  • Top company in Manufacturing Technology and Equipment
  • Top company for Active Pharmaceutical Ingredients development
  • Top company for Analysis, Testing, and Quality Control
  • Top company in Packaging & Drug Delivery services
  • Top company in Supply Chain, Logistics, and Distribution
  • Top company in clinical research-based development
  • Top Innovation & Collaborations in ADC Drug Development
  • Excellence in MedTech Innovations
  • Innovative Space Solutions Awards
  • Innovative Biotech Solutions Award
  • Sustainability in Lab Water Solutions Award
  • Emerging AI-Powered Drug Discovery Platform

Nomination criteria for each-

  • Achievements in CY 2023
  • Challenges faced & solved in CY 2023
  • Novelty/ Uniqueness added in CY 2023
  • Competitive advantage
  • Other efficiencies in CY 2023
  1. Go to the online nomination form.
    • Read the award entry guidelines and eligibility for your reference.
    • Fill out the company information and entrant details fields.
    • Choose the category you'd like to enter.
    • Provide project information: Project title, 500-word summary of the entry, and client testimonial/s (if any).
  2. You will then receive an email confirmation from the BioSpectrum Excellence Awards Organiser after your nomination has been received.
  3. To substantiate your entry, send supporting documents or photos to ankit.kankar@mmactiv.com, manbeena.chawla@mmactiv.com
    • Supporting documents and photos must be in PDF, PowerPoint and/or JPG format
    • For supporting videos, Youtube.com or Vimeo.com links must be provided.
  • 6th December, 2024

CONTACT US

BioSpectrum Asia Excellence
Awards 2024

Sponsorships:
Ankit Kankar
General Manager- Strategy & Marketing
ankit.kankar@mmactiv.com

Speaker Opportunities:
Dr. Manbeena Chawla
Executive Editor
manbeena.chawla@mmactiv.com

Partnership Opportunities:
Apoorva Mahajan
Manager- Strategy & Partnerships
apoorva.mahajan@mmactiv.com

Regional Inquires:
Saradha Mani
General Manager
saradha.mani@mmactiv.com

Attendance & Event Inquires:
Vrushti Kothari
Asst. Manager- Audience & Events
vrushti.kothari@mmactiv.com

© 2022 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer

Web Interface Conceived and Powered By : SCI Knowledge Interlinks